Asst. In Residence Professor
M_MED-CORE-HMON-ONCO-GEN
Dr. Carnevale is a physician-scientist who treats patients with gastrointestinal cancers, and also performs research into finding novel therapies for these diseases.
Publications
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.
Nature communications
Live-cell analyses with unsegmented images to study cancer cell response to modified T cell therapy.
bioRxiv : the preprint server for biology
Abstract PR008: CD4+ T cell rest and activation is enabled by centralized control of state specific regulatory genes.
Cancer immunology research
Understanding TCR T cell knockout behavior using interpretable machine learning.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
Cellular behavior analysis from live-cell imaging of TCR T cell-cancer cell interactions.
bioRxiv : the preprint server for biology
CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial.
Journal of Clinical Oncology
Abstract No. 266 Phase I Prospective Trial of TAS-102 (Trifluridine and Tipiracil) and Radioembolization with 90Y Resin Microspheres for Chemo-Refractory Colorectal Liver Metastases.
Journal of Vascular and Interventional Radiology
Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.
Cancer research
Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology
The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing.
Pancreas
Hypoxia is a dominant remodeler of the effector T cell surface proteome relative to activation and regulatory T cell suppression.
Molecular & cellular proteomics : MCP
512O Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies.
Annals of Oncology
Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair-deficient pancreatic cancer.
Immunotherapy
Investigating tumor molecular profiling as a possible contributor to racial/ethnic disparities in pancreatic cancer.
Journal of Clinical Oncology
The marginal diagnostic benefit of pancreatic cancer molecular profiling after germline testing.
Journal of Clinical Oncology
Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.
Journal of Clinical Oncology
Combined Immunotherapy and Hypofractionated Radiotherapy for Metastatic Cancers.
International Journal of Radiation Oncology • Biology • Physics
Abstract PR08: Discovery of immune regulators in primary human T cells using genome-wide CRISPR screens.
Cancer immunology research
3:54 PM Abstract No. 243 Phase I Prospective Trial of TAS-102 (trifluride and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.
Journal of Vascular and Interventional Radiology
Phase I prospective trial of TAS-102 (trifluride and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.
Journal of Clinical Oncology
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
The Journal of Immunology
Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
Familial cancer
Referral patterns and attrition rate for germline testing in pancreatic cancer (PC) patients.
Journal of Clinical Oncology
Current and Emerging Therapies in Pancreatic Cancer. Editors: Tanios Bekaii-Saab and Bassel Le-Rayes
Targeting the Tumor Microenvironment.
Targeting the Tumor Microenvironment.
Current and Emerging Therapies in Pancreatic Cancer
The Challenge of Primary Central Nervous System Lymphoma.
Hematology/oncology clinics of North America
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer.
Future oncology (London, England)
Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignancies.
Familial cancer
Progress in central nervous system lymphomas.
British journal of haematology
SYK regulates mTOR signaling in AML.
Leukemia
The crimson care collaborative: a student-faculty initiative to increase medical students' early exposure to primary care.
Academic medicine : journal of the Association of American Medical Colleges
Schistosomiasis haematobium prevalence and risk factors in a school-age population of peri-urban Lusaka, Zambia.
Journal of tropical pediatrics